← Back to Search

Analgesic

VVZ-149 Injections for Postoperative Pain

Phase 3
Waitlist Available
Research Sponsored by Vivozon, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-12 hours post-dose
Awards & highlights

Study Summary

This trial will test how well VVZ-149 Injections work to relieve post-operative pain following bunionectomy, and how safe it is.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-12 hours post-dose
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-12 hours post-dose for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time-weighted Sum of Pain Intensity Difference (SPID) from baseline over 12 hours after the start of study drug infusion (i.e., post-dose)
Secondary outcome measures
Proportion of patients who take prescription opioid after discharge
Proportion of patients with >40% improvement in pain from baseline to 6 hours post-dose
Time to onset of perceptible pain relief using the double stopwatch method
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: VVZ-149 InjectionsExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VVZ-149 Injections
2021
Completed Phase 3
~790

Find a Location

Who is running the clinical trial?

Vivozon, Inc.Lead Sponsor
10 Previous Clinical Trials
702 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~63 spots leftby Apr 2025